Serum IgM, IgG and IgA block by F(ab′)2-dependent mechanism the binding of natural IgG autoantibodies from therapeutic immunoglobulin preparations to self-antigens

被引:9
作者
Djoumerska, IK
Tchorbanov, AI
Donkova-Petrini, VD
Pashov, AD
Vassilev, TL
机构
[1] Bulgarian Acad Sci, Stefan Angelov Inst Microbiol, Dept Immunol, BU-1113 Sofia, Bulgaria
[2] Bulgarian Acad Sci, Inst Biol & Immunol Reprod, Lab Mol Immunol, BU-1113 Sofia, Bulgaria
[3] INSERM, U430, Paris, France
[4] UAMC, ACRC, Little Rock, AR USA
关键词
natural autoantibodies; autoimmunity; IVIg; idiotype interactions;
D O I
10.1111/j.1600-0609.2004.00350.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Natural polyreactive IgG autoantibodies are present in the plasma of healthy individuals and as a result in pooled therapeutic intravenous immunoglobulin (IVIg) preparations. The spectrum of self-antigens to which these autoantibodies bind, their fate after intravenous infusion and their biological activity are not well understood. The identity of serum proteins that mask binding of natural autoantibodies to self-proteins is a matter of controversy. The spectrum of native serum proteins bound by IVIg was analyzed by two-dimensional electrophoresis. The reactivity of IVIg was directed mainly to circulating immunoglobulins. The binding of the IgG autoantibodies from IVIg to native human liver antigens was blocked not only by a F(ab')(2)-dependent mechanism by circulating IgM and IgG (as has been previously suggested), but also by serum IgA. This control of anti-self reactivity may be inefficient in some autoimmune diseases.
引用
收藏
页码:101 / 110
页数:10
相关论文
共 55 条
  • [21] SELECTIVE IGA DEFICIENCY AND AUTOIMMUNITY
    LIBLAU, RS
    BACH, JF
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1992, 99 (01) : 16 - 27
  • [22] The primary antibody repertoire represents a linked network of degenerate antigen specificities
    Manivel, V
    Bayiroglu, F
    Siddiqui, Z
    Salunke, DM
    Rao, KVS
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (02) : 888 - 897
  • [23] HUMAN AUTOANTIBODIES REACTIVE WITH SYNTHETIC AUTOANTIGENS FROM T-CELL RECEPTOR BETA-CHAIN
    MARCHALONIS, JJ
    KAYMAZ, H
    DEDEOGLU, F
    SCHLUTER, SF
    YOCUM, DE
    EDMUNDSON, AB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) : 3325 - 3329
  • [24] Polyreactivity as an acquired artefact, rather than a physiologic property, of antibodies: evidence that monoreactive antibodies may gain the ability to bind to multiple antigens after exposure to low pH
    McMahon, MJ
    O'Kennedy, R
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 241 (1-2) : 1 - 10
  • [25] Human polyreactive IgM monoclonal antibodies with blocking activity against self-reactive IgG
    Melero, J
    Tarrago, D
    NunezRoldan, A
    Sanchez, B
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 45 (04) : 393 - 400
  • [26] INVARIANCE AND RESTRICTION TOWARD A LIMITED SET OF SELF-ANTIGENS CHARACTERIZE NEONATAL IGM ANTIBODY REPERTOIRES AND PREVAIL IN AUTOREACTIVE REPERTOIRES OF HEALTHY-ADULTS
    MOUTHON, L
    NOBREGA, A
    NICOLAS, N
    KAVERI, SV
    BARREAU, C
    COUTINHO, A
    KAZATCHKINE, MD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) : 3839 - 3843
  • [27] ANTI-GALACTOSYL ANTIBODIES THAT REACT WITH UNMODIFIED AGAROSE - A POTENTIAL SOURCE OF ARTIFACTS IN IMMUNOAFFINITY CHROMATOGRAPHY
    OSBORN, AH
    KELLEHER, M
    HANDMAN, E
    GODING, JW
    [J]. ANALYTICAL BIOCHEMISTRY, 1994, 217 (02) : 181 - 184
  • [28] Autoantibodies to heat shock protein 90 in the human natural antibody repertoire
    Pashov, A
    Kenderov, A
    Kyurkchiev, S
    Kehayov, I
    Hristova, S
    Lacroix-Desmazes, S
    Giltiay, N
    Varamballi, S
    Kazatchkine, MD
    Kaveri, SV
    [J]. INTERNATIONAL IMMUNOLOGY, 2002, 14 (05) : 453 - 461
  • [29] The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases
    Pyne, D
    Ehrenstein, M
    Morris, V
    [J]. RHEUMATOLOGY, 2002, 41 (04) : 367 - 374
  • [30] Quan CP, 1998, EUR J IMMUNOL, V28, P4001, DOI 10.1002/(SICI)1521-4141(199812)28:12<4001::AID-IMMU4001>3.0.CO